Relative frequency, healthcare resource utilization, and costs of diagnosed drug-induced headache and potential acute medication overuse in patients with migraine

被引：0
|
作者：
Shewale, A. R. [1 ]
Brandenburg, J. A. [2 ]
Burslem, K. [1 ]
Lipton, R. B. [3 ]
Doshi, J. A. [4 ]
机构：
[1] AbbVie, Chicago, IL USA
[2] HealthStatistics, Philadelphia, PA USA
[3] Albert Einstein Coll Med, Bronx, NY 10467 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
来源：
HEADACHE | 2022年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-96
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [31] Healthcare Resource Utilization and Direct Costs Associated with Concomitant Use of Calcitonin Gene-Related Peptide Monoclonal Antibody and Novel Acute Medication in Patients with Migraine
    Hoyt, M.
    Gulati, T.
    Wheeler, A.
    Varnado, O.
    HEADACHE, 2023, 63 : 60 - 60
  • [32] Primary headache disorders and acute abortive medications associated with patients diagnosed with medication overuse headache: Analysis of German EMR data
    Shulman, K. J.
    Ahn, A. H.
    Iyer, R. G.
    Reshef, S.
    Lim, S.
    HEADACHE, 2022, 62 : 42 - 43
  • [33] Eptinezumab Reduced the Frequency of Migraine Days in Patients With Chronic Migraine and Medication-Overuse Headache: Subgroup Analysis of PROMISE-2
    Diener, H.
    Marmura, M.
    Hirman, J.
    Mehta, L.
    Brevig, T.
    Brunner, E.
    Cady, R.
    HEADACHE, 2020, 60 : 107 - 107
  • [34] Eptinezumab Reduced the Frequency of Migraine Days in Patients with Chronic Migraine and Medication-Overuse Headache: Subgroup Analysis of PROMISE-2
    Diener, H. -C.
    Marmura, M.
    Hirman, J.
    Mehta, L.
    Brevig, T.
    Brunner, E.
    Cady, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 155 - 155
  • [35] Healthcare Resource Utilization and Costs in US Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Chemotherapy
    Huggar, David
    Knoth, Russell L.
    Copher, Ronda
    Cao, Zhun
    Lipkin, Craig
    McBride, Ali
    LeBlanc, Thomas W.
    BLOOD, 2021, 138
  • [36] EFFECTIVENESS OF ERENUMAB AND ONABOTULINUMTOXINA ON ACUTE MEDICATION USAGE AND HEALTHCARE RESOURCE UTILIZATION AS MIGRAINE PREVENTION IN THE UNITED STATES
    Tepper, Stewart J.
    Fang, Juanzhi
    Vo, Pamela
    Abdrabboh, Ahmad
    Shen, Ying
    Zhou, Lujia
    Glassberg, Mrudula
    Ferraris, Matias
    CEPHALALGIA, 2020, 40 : 90 - 91
  • [37] Eptinezumab Reduced Acute Medication Use in Patients With Chronic Migraine and Medication-Overuse Headache: Subgroup Analysis of PROMISE-2
    Marmura, M.
    Diener, H.
    Hirman, J.
    Cady, R.
    Brevig, T.
    Brunner, E.
    Mehta, L.
    HEADACHE, 2020, 60 : 107 - 107
  • [38] Eptinezumab Reduced Acute Medication Use in Patients with Chronic Migraine and Medication-Overuse Headache: Subgroup Analysis of PROMISE-2
    Marmura, M.
    Diener, H. -C.
    Hirman, J.
    Cady, R.
    Brevig, T.
    Brunner, E.
    Mehta, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 298 - 298
  • [39] Treatment Patterns and Medication Adherence Among Newly Diagnosed Migraine Patients: A Drug Utilization Study
    Orlando, V.
    Mucherino, S.
    Monetti, V. M.
    Trama, U.
    Menditto, E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (01) : 302 - 303
  • [40] Treatment patterns and medication adherence among newly diagnosed migraine patients: A drug utilization study
    Mucherino, Sara
    Orlando, Valentina
    Monetti, Valeria M.
    Trama, Ugo
    Menditto, Enrica
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 206 - 207
12345